20 Einträge gefunden

1. Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial

   1. Döhner, Hartmut
   2. Weber, Daniela
   3. Krzykalla, Julia
   4. Fiedler, Walter
   5. Kühn, Michael W M
   6. Schroeder, Thomas
   7. Mayer, Karin

   2023 - Forschungsinformationssystem des UKE
2. Midostaurin plus intensive chemotherapy for younger and older Patients with AML and FLT3 internal tandem duplications

   1. Döhner, Hartmut
   2. Weber, Daniela
   3. Krzykalla, Julia
   4. Fiedler, Walter
   5. Wulf, Gerald Georg
   6. Salih, Helmut R
   7. Lübbert, Michael

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group

   1. Rücker, Frank G
   2. Agrawal, Mridul
   3. Corbacioglu, Andrea
   4. Weber, Daniela
   5. Kapp-Schwoerer, Silke
   6. Gaidzik, Verena I
   7. Jahn, Nikolaus

   2019 - Forschungsinformationssystem des UKE
4. Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromes

   1. Ganster, Christina
   2. Müller-Thomas, Catharina
   3. Haferlach, Claudia
   4. Strupp, Corinna
   5. Ogata, Kiyoyuki
   6. Germing, Ulrich
   7. Hildebrandt, Barbara

   2019 - Forschungsinformationssystem des UKE
5. A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia

   1. Döhner, Hartmut
   2. Müller-Tidow, Carsten
   3. Lübbert, Michael
   4. Fiedler, Walter
   5. Krämer, Alwin
   6. Westermann, Jörg
   7. Bug, Gesine

   2019 - Forschungsinformationssystem des UKE
6. Midostaurin added to chemotherapy and continued single agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

   1. Schlenk, Richard F
   2. Weber, Daniela
   3. Fiedler, Walter
   4. Salih, Helmut R
   5. Wulf, Gerald
   6. Salwender, Hans
   7. Schroeder, Thomas

   2019 - Forschungsinformationssystem des UKE
7. Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)

   1. Krauter, Jürgen
   2. Fiedler, Walter
   3. Schlenk, Richard F
   4. Paschka, Peter
   5. Thol, Felicitas
   6. Lübbert, Michael
   7. Wattad, Mohammed

   2018 - Forschungsinformationssystem des UKE
8. Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial

   1. Paschka, Peter
   2. Schlenk, Richard F
   3. Weber, Daniela
   4. Benner, Axel
   5. Bullinger, Lars
   6. Heuser, Michael
   7. Gaidzik, Verena I

   2018 - Forschungsinformationssystem des UKE
9. Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial

   1. Braulke, Friederike
   2. Schulz, Xenia
   3. Germing, Ulrich
   4. Schuler, Esther
   5. Platzbecker, Uwe
   6. Nolte, Florian
   7. Hofmann, Wolf-Karsten

   2017 - Forschungsinformationssystem des UKE
10. The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia

    1. Both, Anna
    2. Krauter, Jürgen
    3. Damm, Frederik
    4. Thol, Felicitas
    5. Göhring, Gudrun
    6. Heuser, Michael
    7. Ottmann, Oliver

    2017 - Forschungsinformationssystem des UKE
11. All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study

    1. Schlenk, Richard F
    2. Lübbert, Michael
    3. Benner, Axel
    4. Lamparter, Alexander
    5. Krauter, Jürgen
    6. Herr, Wolfgang
    7. Martin, Hans

    2016 - Forschungsinformationssystem des UKE
12. Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

    1. Döhner, Hartmut
    2. Lübbert, Michael
    3. Fiedler, Walter
    4. Fouillard, Loic
    5. Haaland, Alf
    6. Brandwein, Joseph M
    7. Lepretre, Stephane

    2014 - Forschungsinformationssystem des UKE
13. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.

    1. Thol, Felicitas
    2. Winschel, Claudia
    3. Sonntag, Ann-Kathrin
    4. Damm, Frederik
    5. Wagner, Katharina
    6. Chaturvedi, Anuhar
    7. Göhring, Gudrun

    2013 - Forschungsinformationssystem des UKE
14. Immune response as a possible mechanism of long-lasting disease control in spontaneous remission of MLL/AF9-positive acute myeloid leukemia.

    1. Müller-Schmah, Claudia
    2. Solari, Leticia
    3. Weis, Roland
    4. Pfeifer, Dietmar
    5. Scheibenbogen, Carmen
    6. Trepel, Martin
    7. May, Annette M

    2012 - Forschungsinformationssystem des UKE
15. Integrative prognostic risk score in acute myeloid leukemia with normal karyotype.

    1. Damm, Frederik
    2. Heuser, Michael
    3. Morgan, Michael
    4. Wagner, Katharina
    5. Görlich, Kerstin
    6. Grosshennig, Anika
    7. Hamwi, Iyas

    2011 - Forschungsinformationssystem des UKE
16. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.

    1. Thol, Felicitas
    2. Damm, Frederik
    3. Lüdeking, Andrea
    4. Winschel, Claudia
    5. Wagner, Katharina
    6. Morgan, Michael
    7. Yun, Haiyang

    2011 - Forschungsinformationssystem des UKE
17. Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia.

    1. Damm, Frederik
    2. Oberacker, Tina
    3. Thol, Felicitas
    4. Surdziel, Ewa
    5. Wagner, Katharina
    6. Chaturvedi, Anuhar
    7. Morgan, Michael

    2011 - Forschungsinformationssystem des UKE
18. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.

    1. Wagner, Katharina
    2. Damm, Frederik
    3. Göhring, Gudrun
    4. Görlich, Kerstin
    5. Heuser, Michael
    6. Schäfer, Irina
    7. Ottmann, Oliver

    2010 - Forschungsinformationssystem des UKE
19. Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.

    1. Thol, Felicitas
    2. Damm, Frederik
    3. Wagner, Katharina
    4. Göhring, Gudrun
    5. Schlegelberger, Brigitte
    6. Hoelzer, Dieter
    7. Lübbert, Michael

    2010 - Forschungsinformationssystem des UKE
20. Single Nucleotide Polymorphism in the Mutational Hotspot of WT1 Predicts a Favorable Outcome in Patients With Cytogenetically Normal Acute Myeloid Leukemia.

    1. Damm, Frederik
    2. Heuser, Michael
    3. Morgan, Michael
    4. Yun, Haiyang
    5. Großhennig, Anika
    6. Göhring, Gudrun
    7. Schlegelberger, Brigitte

    2009 - Forschungsinformationssystem des UKE